Chuanming Hao

9PUBLICATIONS
39CO-AUTHORS
Developmental genetics (incl. sex determination)Poverty, inclusivity and wellbeingApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 17, 2026
Sex Dimorphism of NAD +De Novo Biosynthesis Mediates Sex-Biased Susceptibility to Ischemia-Reperfusion-Induced Acute Kidney Injury.

|Sep 23, 2025
Implementation of Established Global Guidelines in the Management of CKD in Patients with Type 2 Diabetes in Asia.

Rajiv Agarwal, Masaomi Nangaku, Liming Chen

|Nov 07, 2024
Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic.

Mingyue Xu, Ruiying Chen, Yifeng Wang

|Oct 14, 2024
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy.

Mingyue Xu, Yifeng Wang, Meihe Wu

|May 08, 2024
Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.

Ping Cheng, Qionghong Xie, Shaojun Liu

|Dec 08, 2023
Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I 2 Receptor.

Jing Li, Yi Guan, Yunyu Xu

Pageof 2

Frequent Collaborators

3 joint publications

Yi Guan

2 joint publications

Shaojun Liu

2 joint publications

Qionghong Xie

2 joint publications

Mingyue Xu